Insurers Drop Coverage for More Than 600 Drugs
Year In Review: The Conversations That Shaped Health Policy in 2023
IgG4-RD and Mental Health
The ORPHAN Cures Act’s Promise for Rare Disease Patients
IgG4-RD and Mental Health
Thyroid Eye Disease in the Spotlight
Diagnosing IgG4-RD Patients
Veterans with hATTR Amyloidosis Need Access to Critical Meds
Overcoming Barriers for Patients with Rare Vision Conditions
Updated: Putting Genetic Science to Work for Patients
